Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation · 2020-11 · 26 (11) · 2053-2060
DOI: 10.1016/j.bbmt.2020.07.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-11. Verfasst von John S Tanaka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Durham, North Carolina. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, AHRQ HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Duke University School of Medicine, Durham, North Carolina.
- Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina.
- Department of Health Policy and Management, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, North Carolina; Lineberger Comprehensive Cancer Center, University of North…
- Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
- Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, North Carolina.
- Center for Microbiome Research, University of Massachusetts Medical School, Worcester, Massachusetts; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachu…
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- AHRQ HHS
- NCI NIH HHS
- NICHD NIH HHS
- Derfner Foundation
- Agency for Healthcare Research and Quality
- National Cancer Institute
Zitieren
APA
Tanaka, J. S., Young, R. R., Heston, S. M., Jenkins, K., Spees, L. P., Sung, A. D., Corbet, K., Thompson, J. C., Bohannon, L., Martin, P. L., Stokhuyzen, A., Vinesett, R., Ward, D. V., Bhattarai, S. K., Bucci, V., Arshad, M., Seed, P. C., & Kelly, M. S. (2020). Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 26(11), 2053-2060. https://doi.org/10.1016/j.bbmt.2020.07.011
Vancouver
Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, et al. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2020;26(11):2053-2060. doi:10.1016/j.bbmt.2020.07.011
BibTeX
@article{Tanaka2020,
author = {Tanaka, John S and Young, Rebecca R and Heston, Sarah M and Jenkins, Kirsten and Spees, Lisa P and Sung, Anthony D and Corbet, Kelly and Thompson, Jillian C and Bohannon, Lauren and Martin, Paul L and Stokhuyzen, Andre and Vinesett, Richard and Ward, Doyle V and Bhattarai, Shakti K and Bucci, Vanni and Arshad, Mehreen and Seed, Patrick C and Kelly, Matthew S},
title = {Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation},
journal = {Biology of Blood and Marrow Transplantation},
year = {2020},
volume = {26},
number = {11},
pages = {2053--2060},
doi = {10.1016/j.bbmt.2020.07.011}
}
EUVIMED